Unit of Geriatrics, Campus Biomedico University, Rome, Italy; Fondazione Alberto Sordi, Rome, Italy.
Ann Allergy Asthma Immunol. 2013 Nov;111(5):382-6. doi: 10.1016/j.anai.2013.08.013. Epub 2013 Sep 10.
Clinical and epidemiologic evidence on asthma in the elderly is scant. There is evidence that forced expiratory volume in the first second (FEV1), a commonly used indicator of overall pulmonary function, might not be an independent predictor of 5-year mortality in elderly patients with asthma.
To investigate the association between FEV1 expressed using 3 alternative methods and 5-, 10-, and 15-year mortality in a population of elderly patients with asthma.
Participants in the Salute Respiratoria nell' Anziano study were included. Asthma was diagnosed at baseline according to spirometric and clinical data. Vital status at 15 years was assessed using death registries. FEV1 was expressed as percentage of predicted, divided by height cubed, and as a multiple of the sex-specific first percentile. The association between FEV1 and mortality was evaluated using Cox proportional hazard models.
Two hundred patients were studied (52% women, mean age 73.1 years, standard deviation 6.2 years). All FEV1 measurements were associated with mortality at unadjusted analysis. After correction for potential confounders, no association was found between FEV1 and 5-year mortality. Only FEV1 as a multiple of the sex-specific first percentile was independently associated with 10-year (hazard ratio 0.35, 95% confidence interval 0.14-0.87) and 15-year (hazard ratio 0.38, 95% confidence interval 0.19-0.79) mortality.
Although extensively used, FEV1 expressed as percentage of predicted does not seem to be the best predictor of mortality in elderly patients with asthma. Although no spirometric index can predict 5-year mortality in this population, FEV1 as a multiple of the sex-specific first percentile should be considered when longer-term prognostic stratification is needed.
老年人哮喘的临床和流行病学证据很少。有证据表明,第一秒用力呼气量(FEV1),一种常用的整体肺功能指标,可能不是老年哮喘患者 5 年死亡率的独立预测指标。
研究 3 种替代方法表示的 FEV1 与老年哮喘患者 5 年、10 年和 15 年死亡率之间的关系。
纳入 Salute Respiratoria nell' Anziano 研究的参与者。根据肺活量和临床数据在基线时诊断哮喘。使用死亡登记处评估 15 年的生存状态。FEV1 表示为预计值的百分比,除以身高的立方,以及性别特异性第 1 百分位数的倍数。使用 Cox 比例风险模型评估 FEV1 与死亡率之间的关系。
共研究了 200 名患者(52%为女性,平均年龄 73.1 岁,标准差 6.2 岁)。所有 FEV1 测量值在未校正分析中均与死亡率相关。在校正潜在混杂因素后,FEV1 与 5 年死亡率之间没有关联。只有 FEV1 作为性别特异性第 1 百分位数的倍数与 10 年(风险比 0.35,95%置信区间 0.14-0.87)和 15 年(风险比 0.38,95%置信区间 0.19-0.79)死亡率独立相关。
尽管广泛使用,但预测死亡率时,预计值的百分比表示的 FEV1 似乎不是老年哮喘患者的最佳预测指标。尽管在该人群中没有任何肺活量指标可以预测 5 年死亡率,但在需要进行长期预后分层时,应考虑将 FEV1 作为性别特异性第 1 百分位数的倍数。